STAT+: Pharmalittle: We’re reading about FDA voucher worries, weight loss drugs and jet fuel, and more
Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines over possible legal risks
Espace publicitaire · 300×250